Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema

Conclusion: Intravitreal dexamethasone as initial therapy in the treatment of DME is both safe and efficacious in the reduction of CMT and improvement of vision and can be considered as primary therapy for DME.

Source: Indian Journal of Ophthalmology - February 13, 2020 Category: Opthalmology Authors: Santosh Kumar Mahapatra Swati Kumari Source Type: research